BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23342095)

  • 1. Analysis of substrate specificity and kinetics of cyclic nucleotide phosphodiesterases with N'-methylanthraniloyl-substituted purine and pyrimidine 3',5'-cyclic nucleotides by fluorescence spectrometry.
    Reinecke D; Schwede F; Genieser HG; Seifert R
    PLoS One; 2013; 8(1):e54158. PubMed ID: 23342095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Non-canonical Cyclic Nucleotides: Hydrolysis and Transport.
    Schneider EH; Seifert R
    Handb Exp Pharmacol; 2017; 238():169-205. PubMed ID: 28204955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cCMP and cUMP: emerging second messengers.
    Seifert R
    Trends Biochem Sci; 2015 Jan; 40(1):8-15. PubMed ID: 25435399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides.
    Wolter S; Golombek M; Seifert R
    Biochem Biophys Res Commun; 2011 Dec; 415(4):563-6. PubMed ID: 22074826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP, cGMP, cCMP and cUMP concentrations across the tree of life: High cCMP and cUMP levels in astrocytes.
    Hartwig C; Bähre H; Wolter S; Beckert U; Kaever V; Seifert R
    Neurosci Lett; 2014 Sep; 579():183-7. PubMed ID: 25062586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal Chemistry of the Noncanonical Cyclic Nucleotides cCMP and cUMP.
    Schwede F; Rentsch A; Genieser HG
    Handb Exp Pharmacol; 2017; 238():307-337. PubMed ID: 27896476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From canonical to non-canonical cyclic nucleotides as second messengers: pharmacological implications.
    Seifert R; Schneider EH; Bähre H
    Pharmacol Ther; 2015 Apr; 148():154-84. PubMed ID: 25527911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cCMP and cUMP Substrate Proteins and Cross Talk Between cNMPs.
    Schlossmann J; Wolfertstetter S
    Handb Exp Pharmacol; 2017; 238():149-167. PubMed ID: 26721673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode.
    Scharrenbroich J; Kaever V; Dove S; Seifert R; Schneider EH
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):199-208. PubMed ID: 30443663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cUMP hydrolysis by PDE3A.
    Berrisch S; Ostermeyer J; Kaever V; Kälble S; Hilfiker-Kleiner D; Seifert R; Schneider EH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):269-280. PubMed ID: 27975297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances, Perspectives and Potential Engineering Strategies of Light-Gated Phosphodiesterases for Optogenetic Applications.
    Tian Y; Yang S; Gao S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Phosphodiesterase-Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity.
    Tulsian NK; Sin VJ; Koh HL; Anand GS
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cCMP and cUMP Across the Tree of Life: From cCMP and cUMP Generators to cCMP- and cUMP-Regulated Cell Functions.
    Seifert R
    Handb Exp Pharmacol; 2017; 238():3-23. PubMed ID: 28181008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report on the Third Symposium "cCMP and cUMP as New Second Messengers".
    Schneider EH; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):1-3. PubMed ID: 25471064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme assays for cGMP hydrolyzing phosphodiesterases.
    Rybalkin SD; Hinds TR; Beavo JA
    Methods Mol Biol; 2013; 1020():51-62. PubMed ID: 23709025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity.
    Brescia M; Zaccolo M
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated.
    Reinecke D; Burhenne H; Sandner P; Kaever V; Seifert R
    FEBS Lett; 2011 Oct; 585(20):3259-62. PubMed ID: 21920362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic CMP and cyclic UMP mediate bacterial immunity against phages.
    Tal N; Morehouse BR; Millman A; Stokar-Avihail A; Avraham C; Fedorenko T; Yirmiya E; Herbst E; Brandis A; Mehlman T; Oppenheimer-Shaanan Y; Keszei AFA; Shao S; Amitai G; Kranzusch PJ; Sorek R
    Cell; 2021 Nov; 184(23):5728-5739.e16. PubMed ID: 34644530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of cyclic nucleotide hydrolysis in the phosphodiesterase catalytic site.
    Salter EA; Wierzbicki A
    J Phys Chem B; 2007 May; 111(17):4547-52. PubMed ID: 17425352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal and organ-specific detection of cNMPs including cUMP in the zebrafish.
    Dittmar F; Abdelilah-Seyfried S; Tschirner SK; Kaever V; Seifert R
    Biochem Biophys Res Commun; 2015 Dec; 468(4):708-12. PubMed ID: 26551461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.